Press "Enter" to skip to content

New patent for Promius Pharma drug SERNIVO

0
Copyright © DrugPatentWatch. Originally published at New patent for Promius Pharma drug SERNIVO

Annual Drug Patent Expirations for SERNIVO
Annual Drug Patent Expirations for SERNIVO

Sernivo is a drug marketed by Promius Pharma Llc and is included in one NDA. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge.

SERNIVO drug price trends.

Drug patent litigation for SERNIVO.

This drug has six patent family members in five countries.

The generic ingredient in SERNIVO is betamethasone dipropionate. One supplier is listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Promius Pharma drug SERNIVO
    Do NOT follow this link or you will be banned from the site!